Mrs Sheila Nankoberanyi
Clinical Research Coordinator
Baker IDI Heart and Diabetes Institute
s.nankoberanyi@nucleusnetwork.com.au
Research Activities
I have previously worked with P. Falciparum malaria in collaboration with a group from University of California San Francisco, specifically studying drug resistance & genetic factors underlying treatment outcomes in Uganda. To this end, I evaluated a high throughput genotypic technique for surveillance of SNPs mediating drug resistance; and characterized the distribution of markers & their clinical relevance. And we managed to publish three papers out of this work, which can be accessed online. To date I have expanded my interests to Onchocerciasis eradication through novel molecular and genomic tools. Here we aim to develop novel diagnostic tools for onchocerciasis & identify genetic markers for disease surveillance across different epidemiological zones. So far, I have developed a Loop mediated isothermal amplification (LAMP) assay for point of care applications with regards to onchocerciasis. Cumulatively, I have gained a lot of experience in molecular epidemiology specifically employing state of the art genomic tools to solve prominent infectious disease problems.Techniques/Expertise
Molecular epidemiology, drug resistance, nematode genomics, assay development, next generation sequencing, translation researchCollaborations
University of California San FransiscoWHO/TDR
Diagnostics For All
Disease Models
C. elegans for Alzheimer’s diseaseBush Rats for Onchocerciasis pathophysiology studies
Possums for parasite evolution studies